MetaCap

Cardio Diagnostics (CDIO) vs Q/C Technologies (QCLS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cardio Diagnostics is the larger company by market cap ($4.7 million vs $2.4 million), about 2.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDIO-18.37%QCLS-55.95%
+4%-28%-59%
Oct 7, 20261 yearNov 20, 2026
CDIO-14.44%QCLS-55.81%
+4%-27%-59%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDIO versus QCLS key metrics
MetricCDIOQCLS
Share price$1.60$0.2784
Market cap$4.74M$2.40M
1-day change-3.03%-6.01%
P/E ratio (TTM)—0.06
EPS (TTM)$-2.52$4.69
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$14.82K—
Revenue growth (YoY)-57.51%—
Net income (latest FY)$-6.50M$-11.63M
Operating margin-43737.46%—
Net margin-43832.49%—
52-week high$7.91$8.17
52-week low$0.97$0.275
Distance from 52-week high-79.77%-96.59%
Average volume26.91K5.05M
Shares outstanding2.96M8.62M
Employees153
SectorHealth CareHealth Care
IndustryBiotechnology: In Vitro & In Vivo Diagnostic SubstancesBiotechnology: In Vitro & In Vivo Diagnostic Substances

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Cardio Diagnostics

CDIO stock →

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 15 employees

About Q/C Technologies

QCLS stock →

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company.

Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 3 employees

CDIO vs QCLS FAQ

Which is bigger, Cardio Diagnostics or Q/C Technologies?

Cardio Diagnostics (CDIO) is larger, with a market capitalization of $4.74M compared with $2.40M for Q/C Technologies (QCLS).

Are Cardio Diagnostics and Q/C Technologies in the same industry?

Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.

More comparisons